todayonchain.com

Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug

CryptoSlate
Enlivex is asking shareholders to approve a massive stock dilution of up to 951% to finance the acquisition of the RAIN crypto token.

Summary

Full summary available to members

Subscribe to TodayOnChain membership to read full news summaries and browse without display ads.